Keyphrases
Head-and-neck
100%
Locally Advanced
100%
Squamous Cell Carcinoma of Head
100%
Advanced Squamous Cell Carcinoma
100%
Induction Chemotherapy
100%
Cetuximab
100%
Progression-free Survival
75%
Local Therapy
50%
Risky Driving
50%
Chemotherapy
25%
Fever
25%
Tumor
25%
Working Diagnosis
25%
Locoregional Disease
25%
Clinical Response
25%
Disease Progression
25%
High-risk Human Papillomavirus (HR-HPV)
25%
Nodal Disease
25%
Overall Survival
25%
Paclitaxel
25%
Complete Response
25%
Phase II Trial
25%
Neutropenia
25%
Area under the Curve
25%
Good Prognosis
25%
HPV16
25%
Partial Response
25%
Tumor Site
25%
Tumor Stage
25%
Previously Untreated Patients
25%
Carboplatin
25%
Systemic Disease
25%
Overall Survival Rate
25%
Oropharynx
25%
Concurrent Chemoradiotherapy
25%
Skin Rash
25%
Performance Status
25%
Follow-up Time
25%
Radiological Response
25%
Chemotherapy Patients
25%
Concurrent Surgery
25%
Weekly Cycle
25%
Sequential Treatment Strategies
25%
Medicine and Dentistry
Squamous Cell Carcinoma
100%
Neck
100%
Induction Chemotherapy
100%
Cetuximab
100%
Progression Free Survival
75%
Overall Survival
50%
Local Therapy
50%
Survival Rate
25%
Wart Virus
25%
Disease Exacerbation
25%
Chemoradiotherapy
25%
Biopsy Technique
25%
Exanthem
25%
Cancer Staging
25%
Human Papillomavirus Type 16
25%
Systemic Disease
25%
Carboplatin
25%
Oropharynx
25%
Paclitaxel
25%
Neutropenia
25%
Phase II Trials
25%
Tumor
25%
Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Squamous Cell Carcinoma
100%
Cetuximab
100%
Progression Free Survival
60%
Overall Survival
40%
Survival Rate
20%
Disease Exacerbation
20%
Human Papillomavirus
20%
Rash
20%
Paclitaxel
20%
Cancer Staging
20%
Phase II Trials
20%
Neutropenia
20%
Carboplatin
20%
Systemic Disease
20%
Chemoradiation Therapy
20%
Human Papillomavirus Type 16
20%
Diseases
20%